Abstrait
Les patientes exposées in utero au DES sont aujourd’hui situées dans les tranches d’âges où la fréquence du cancer du sein est élevée. Ainsi, le rôle de l’exposition in utero au DES dans la survenue d’un cancer du sein est important à connaître afin d’adapter notre conduite à tenir et l’information à donner à ces patientes.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
Trichopoulos D (1990) Does breast cancer originate in utero? Lancet 335: 939–40
Ekbom A, Hsieh CC, Lipworth L et al. (1997) Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 89: 71–6
Hsieh CC, Lan SJ, Ekbom A et al. (1992) Twin membership and breast cancer risk. Am J Epidemiol 136: 1321–6
Weiss HA, Potischman NA, Brinton LA et al. (1997) Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 8: 181–7
Ekbom A, Trichopoulos D, Adami HO et al. (1992) Evidence of prenatal influences on breast cancer risk. Lancet 340(8826): 1015–8
MacLachlan JA. The role of experimental model systems in the study of DES-associated malignancy. NIH Workshop long-term effects of exposure to diethylstibestrol 1992
Hovey RC, Asai-Sato M, Warri A et al. (2005) Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod 72(2): 423–35
Rothschild TC, Boylan ES, Calhoon RE et al. (1987). Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res 47(16): 4508–16
Titus-Ernstoff L, Hatch EE, Hoover RN et al. (2001) Long term cancer risk in women given disthylstilbestrol (DES) during pregnancy. Br J Cancer 84: 126–33
Calle EE, Mervis CA, Thun MJ et al. (1996) Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol 144: 645–52
Colton T Greenberg ER, Noller K et al. (1993) Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA 269: 2096–100
Greenberg ER, Barnes AB, Resseguie L et al. (1984) Breast cancer in mothers given diethylstilbestrol in pregnancy. New Engl J Med 311: 1393–8
Innes K, Byers T, Schymura M (2000) Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol 152: 1121–8
Sanderson M, Williams M, Malone K et al. (1996) Perinatal factors and risk of breast cancer. Epidemiology 7: 34–7
Braun MM, Ahlbom A, Floderus B et al. (1995) Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control 6: 519–24
Le Marchand L, Kolonel L, Myers BC et al. (1988) Birth characteristics of pre-menopausal women with breast cancer. Br J Cancer 57: 437–9
Hatch EE, Palmer JR, Titus-Ernstoff L et al. (1998) Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 280: 630–4
Palmer JR, Hatch EE, Rosenberg CL et al. (2002) Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control 13: 753–8
Palmer JR, Wise LA, Hatch EE et al. (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15: 1509–14
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Agostini, A. (2007). DES et cancer du sein : mythe ou réalité ?. In: Le Distilbène® trente ans après. Springer, Paris. https://doi.org/10.1007/978-2-287-73307-9_10
Download citation
DOI: https://doi.org/10.1007/978-2-287-73307-9_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-73306-2
Online ISBN: 978-2-287-73307-9